Bio-Techne (TECH) Misses Q1 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Bio-Techne Releases First Quarter Fiscal 2016 Results
October 28, 2015 7:01 AM EDTMINNEAPOLIS, Oct. 28, 2015 /PRNewswire/ --Â Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2015.
First Quarter 2016 Snapshot
Increased first quarter revenue by 4% to $112.4 million. Delivered first quarter adjusted earnings of $29.4 million, down 10% from the prior year due to FX headwinds and the timing of acquisitions in the prior year. Generated operating cash flow of $31.8 million. Continued the trend of double-digit growth in China. Achieved solid growth in the BioPharma end-markets, with a return to... MoreBio-Techne Certifies over 1,000 Antibodies for Simple Western
October 26, 2015 8:30 AM EDTMINNEAPOLIS, Oct. 26, 2015 /PRNewswire/ -- Bio-Techne Corporation announced today that its R&D Systems®, Novus Biologicals®, and ProteinSimple® brands have collaborated to certify over 1,000 antibodies for the Simple Western platform. This milestone demonstrates the power of combining premier reagent providers with innovative protein analysis systems.  The combination will enable scientists to easily transition to quantifying proteins with the Simple Western system from the tedious and semi-quantitative Western Blot method in use today.Â
"Antibody validation and reproducibility are a continuing concern in our industry," says Dr. Birte Aggeler, Director of Antibody Development at R&D Systems. "The Simple Western... More
